You are viewing the site in preview mode

Skip to main content

Table 2

From: Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction

Subject Sex Baseline NYHA Heart Failure Class BASELINE 12 MONTHS
    Myocardial T2* (ms) LVEF (%) Myocardial T2* (ms) LVEF (%)
1 F I 5.2 59 6.2 70
2 M I 6.0 28 6.4 57
3 M I 6.5 50 10.0 68
4 M I 6.4 42 9.2 63
5 M II 5.6 30 6.1 47
6 M I 5.0 57 5.4 73
7 F I 4.8 60 5.5 74
8 F III 5.3 43 7.6 67
9 F I 5.0 54 8.1 67
10 M I 5.7 58 6.6 67
11 F I 5.4 49 10.4 66
12 F I 7.3 61 11.5 70
13 F I 3.7 61 4.8 61
14 F I 7.4 60 13.2 65
15 F I 6.1 56 7.1 69